An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain

Vaccine

Volumn 26, Issue 41, 2008, Pages 5276-5288

  Bakshi, Chandra Shekhar ^a   Malik, Meenakshi ^a   Mahawar, Manish ^a   Kirimanjeswara, Girish S ^a   Hazlett, Karsten R O ^a   Palmer, Lance E ^b   Furie, Martha B ^b   Singh, Rajendra ^c   Melendez, J Andres ^a   Sellati, Timothy J ^a   Metzger, Dennis W ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c INDIAN VETERINARY RESEARCH INSTITUTE   (India)

Author keywords

Francisella; Mice; Superoxide dismutase; Vaccine

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHAPERONIN; FRANCISELLA TULARENSIS LIVE VACCINE; IRON SUPEROXIDE DISMUTASE; LIVE VACCINE; PROTEIN BFR; PROTEIN DNAK; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG POTENCY; FEMALE; FRANCISELLA TULARENSIS; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SODB FT GENE; TULAREMIA; UPREGULATION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; FRANCISELLA TULARENSIS; HEAT-SHOCK PROTEINS; MALE; MICE; MICE, INBRED C57BL; RESPIRATORY TRACT INFECTIONS; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS; TULAREMIA; UP-REGULATION; VACCINES, INACTIVATED;

EID: 50849117147     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.051     Document Type: Article

References (52)

1. Oyston P.C., Sjostedt A., and Titball R.W. Tularaemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol 2 December (12) (2004) 967-978
2. Saslaw S., and Carlisle H.N. Studies with tularemia vaccines in volunteers. IV. Brucella aggiutinins in vaccinated and nonvaccinated volunteers challenged with Pasteurella tularensis. Am J Med Sci 242 August (1961) 166-172
3. Burke D.S. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis 135 January (1) (1977) 55-60
4. Hornick R.B., and Eigelsbach H.T. Aerogenic immunization of man with live Tularemia vaccine. Microbiol Mol Biol Rev 30 September (3) (1966) 532-538
5. Eigelsbach H.T., Hunter D.H., Janssen W.A., Dangerfield H.G., and Rabinowitz S.G. Murine model for study of cell-mediated immunity: protection against death from fully virulent Francisella tularensis infection. Infect Immun 12 November (5) (1975) 999-1005
6. Conlan J.W. Vaccines against Francisella tularensis-past, present and future. Expert Rev Vaccines 3 June (3) (2004) 307-314
7. Wu T.H., Hutt J.A., Garrison K.A., Berliba L.S., Zhou Y., and Lyons C.R. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A. Infect Immun 73 May (5) (2005) 2644-2654
8. Shen H., Chen W., and Conlan J.W. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen. Vaccine 22 June (17-18) (2004) 2116-2121
9. KuoLee R., Harris G., Conlan J.W., and Chen W. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. Vaccine 25 May (19) (2007) 3781-3791
10. Sansone A., Watson P.R., Wallis T.S., Langford P.R., and Kroll J.S. The role of two periplasmic copper- and zinc-cofactored superoxide dismutases in the virulence of Salmonella choleraesuis. Microbiology 148 March (3) (2002) 719-726
11. Karavolos M.H., Horsburgh M.J., Ingham E., and Foster S.J. Role and regulation of the superoxide dismutases of Staphylococcus aureus. Microbiology 149 October (10) (2003) 2749-2758
12. Larsson P., Oyston P.C., Chain P., Chu M.C., Duffield M., Fuxelius H.H., et al. The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat Genet 37 February (2) (2005) 153-159
13. Bakshi C.S., Malik M., Regan K., Melendez J.A., Metzger D.W., Pavlov V.M., et al. Superoxide dismutase B gene (sodB)-deficient mutants of Francisella tularensis demonstrate hypersensitivity to oxidative stress and attenuated virulence. J Bacteriol 188 September (17) (2006) 6443-6448
14. Gil H., Platz G.J., Forestal C.A., Monfett M., Bakshi C.S., Sellati T.J., et al. Deletion of TolC orthologs in Francisella tularensis identifies roles in multidrug resistance and virulence. Proc Natl Acad Sci USA 103 August (34) (2006) 12897-12902
15. Wayne C.J., Shen H., Kuolee R., Zhao X., and Chen W. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma-dependent mechanism. Vaccine 23 March (19) (2005) 2477-2485
16. Malik M., Bakshi C.S., Sahay B., Shah A., Lotz S.A., and Sellati T.J. Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis. Infect Immun 74 June (6) (2006) 3657-3662
17. Gentleman R., Carey V., Bates D., Bolstad B., Dettling M., Dudoit S., et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5 10 (2004) R80
18. Smyth G.K. Linear models and empirical Bytes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3 1 (2008) [Article 3]
19. Malik M., Bakshi C.S., McCabe K., Catlett S.V., Shah A., Sahay B., et al. Matrix metalloproteinase 9 activity enhances host susceptibility to pulmonary infection with type A and B strains of Francisella tularensis. J Immunol 178 January (2) (2007) 1013-1020
20. Baron S.D., Singh R., and Metzger D.W. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Infect Immun 75 May (5) (2007) 2152-2162
21. Chiavolini D., Alroy J., King C.A., Jorth P., Weir S., Madico G., et al. Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia. Infect Immun 76 February (2) (2008) 486-496
22. Morgan R.W., Christman M.F., Jacobson F.S., Storz G., and Ames B.N. Hydrogen peroxide-inducible proteins in Salmonella typhimurium overlap with heat shock and other stress proteins. PNAS 83 November (21) (1986) 8059-8063
23. Ericsson M., Tarnvik A., Kuoppa K., Sandstrom G., and Sjostedt A. Increased synthesis of DnaK, GroEL, and GroES homologs by Francisella tularensis LVS in response to heat and hydrogen peroxide. Infect Immun 62 January (1) (1994) 178-183
24. Twine S.M., Petit M.D., Shen H., Mykytczuk N.C., Kelly J.F., and Conlan J.W. Immunoproteomic analysis of the murine antibody response to successful and failed immunization with live anti-Francisella vaccines. Biochem Biophys Res Commun 346 August (3) (2006) 999-1008
25. Twine S., Bystrom M., Chen W., Forsman M., Golovliov I., Johansson A., et al. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect Immun 73 December (12) (2005) 8345-8352
26. Tempel R., Lai X.H., Crosa L., Kozlowicz B., and Heffron F. Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge. Infect Immun 74 September (9) (2006) 5095-5105
27. Mohapatra N.P., Soni S., Bell B.L., Warren R., Ernst R.K., Muszynski A., et al. Identification of an orphan response regulator required for Francisella virulence and transcription of pathogenicity island genes. Infect Immun July (7) (2007) 3305-3314
28. Sebastian S., Dillon S.T., Lynch J.G., Blalock L.T., Balon E., Lee K.T., et al. A defined o-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect Immun 75 May (5) (2007) 2591-2602
29. Raynaud C., Meibom K.L., Lety M.A., Dubail I., Candela T., Frapy E., et al. Role of the wbt Locus of Francisella tularensis in lipopolysaccharide O-antigen biogenesis and pathogenicity. Infect Immun 75 January (1) (2007) 536-541
30. Quarry J.E., Isherwood K.E., Michell S.L., Diaper H., Titball R.W., and Oyston P.C.F. A Francisella tularensis subspecies novicida purF mutant, but not a purA mutant, induces protective immunity to tularemia in mice. Vaccine 25 March (11) (2007) 2011-2018
31. Pechous R., Celli J., Penoske R., Hayes S.F., Frank D.W., and Zahrt T.C. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Infect Immun 74 August (8) (2006) 4452-4461
32. Lyons R., and Wu T. Animal models of Francisella tularensis infection. Ann NY Acad Sci 29 June (1105) (2007) 238-265
33. Chen W., Shen H., Webb A., Kuolee R., and Conlan J.W. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. Vaccine 21 September (25-26) (2003) 3690-3700
34. Ulloa L., and Tracey K.J. The [']cytokine profile': a code for sepsis. Trends Mol Med 11 February (2) (2005) 56-63
35. Healey G.D., Elvin S.J., Morton M., and Williamson E.D. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Infect Immun 73 September (9) (2005) 5945-5951
36. Eyles JE, Unal B, Hartley MG, Newstead SL, Flick-Smith H, Prior JL, et al. Immunodominant Francisella tularensis antigens identified using proteome microarray. Proteomics.
37. Rawool D.B., Bitsaktsis C., Li Y., Gosselin D.R., Lin Y., Kurkure N.V., et al. Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis. J Immunol 180 April (8) (2008) 5548-5557
38. Stenmark S., Lindgren H., Tarnvik A., and Sjostedt A. Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica. Microb Pathog 35 August (2) (2003) 73-80
39. Drabick J.J., Narayanan R.B., Williams J.C., Leduc J.W., and Nacy C.A. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine. Am J Med Sci 308 August (2) (1994) 83-87
40. Fulop M., Mastroeni P., Green M., and Titball R.W. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 19 August (31) (2001) 4465-4472
41. Pammit M.A., Raulie E.K., Lauriano C.M., Klose K.E., and Arulanandam B.P. Intranasal vaccination with a defined attenuated Francisella novicida strain induces gamma interferon-dependent antibody-mediated protection against tularemia. Infect Immun 74 April (4) (2006) 2063-2071
42. Kirimanjeswara G.S., Golden J.M., Bakshi C.S., and Metzger D.W. Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis. J Immunol 179 July (1) (2007) 532-539
43. Conlan J.W., Shen H., Webb A., and Perry M.B. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen. Vaccine 20 October (29-30) (2002) 3465-3471
44. Twine S.M., Mykytczuk N.C., Petit M.D., Shen H., Sjostedt A., Wayne Conlan J., et al. In vivo proteomic analysis of the intracellular bacterial pathogen, Francisella tularensis, isolated from mouse spleen. Biochem Biophys Res Commun 345 July (4) (2006) 1621-1633
45. Horwitz M.A., Lee B.E., Dillon B.J., and Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. PNAS 92 February (5) (1995) 1530-1534
46. Christman M.F., Storz G., Ames B.N., and OxyR. a positive regulator of hydrogen peroxide-inducible genes in Escherichia coli and Salmonella typhimurium, is homologous to a family of bacterial regulatory proteins. Proc Natl Acad Sci USA 86 (1989) 3484-3488
47. Lenco J., Pavkova I., Hubalek M., and Stulik J. Insights into the oxidative stress response in Francisella tularensis LVS and its mutant [Delta]iglC1 + 2 by proteomics analysis. FEMS Microbiol Lett 246 May (1) (2005) 47-54
48. Ericsson M., Kroca M., Johansson T., Sjostedt A., and Tarnvik A. Long-lasting recall response of CD4+ and CD8+ alphabeta T cells, but not gammadelta T cells, to heat shock proteins of Francisella tularensis. Scand J Infect Dis 33 2 (2001) 145-152
49. Golovliov I., Ericsson M., Sandstrom G., Tarnvik A., and Sjostedt A. Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein. Infect Immun 65 June (6) (1997) 2183-2189
50. Lee B.Y., Horwitz M.A., and Clemens D.L. Identification, recombinant expression, immunolocalization in macrophages, and T-cell responsiveness of the major extracellular proteins of Francisella tularensis. Infect Immun 74 July (7) (2006) 4002-4013
51. Havlasova J., Hernychova L., Brychta M., Hubálek M., Lenco J., Larsson P., et al. Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia. Proteomics 5 May (8) (2005) 2090-2103
52. Havlasova J., Hernychova L., Halada P., Pellantová V., Krejsek J., Stulík J., et al. Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain. Proteomics 2 July (7) (2002) 857-867